Clinic
PM Investments and Consulting, INC.
PM Investments and Consulting, INC. was paid $1.29M by Medicaid between Jan 2018 and Dec 2024, across 69 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 32% of everything it billed.
33Billing provider infoPM INVESTMENTS AND CONSULTING, INC.
LAFAYETTE, LA 70506
LAFAYETTE, LA 70506
33aNPI1366659849assigned 05/16/2007
33bProvider typePrimary Care Clinic/Center
28Total paid$1.29M
24GClaims69,832
24DCodes billed69
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Louisiana
Rank by total paid#19 of 92
Median peer was paid$157K
This provider vs. median8.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,723 | $75K | |
| 2019 | 5,790 | $104K | |
| 2020 | 8,468 | $120K | |
| 2021 | 13,224 | $296K | |
| 2022 | 15,616 | $280K | |
| 2023 | 16,104 | $259K | |
| 2024incomplete | 5,907 | $153K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 32% | 11,205 | 7,903 | $407K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 11% | 2,776 | 2,137 | $146K |
| 86328 | 7.6% | 6,253 | 3,053 | $98K | |
| 96521 | 6.8% | 1,856 | 662 | $88K | |
| 93922 | 6.5% | 2,328 | 1,773 | $84K | |
| 93925 | 5.3% | 622 | 559 | $68K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4.1% | 2,852 | 1,600 | $53K |
| 93880 | 4.0% | 595 | 529 | $52K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.8% | 2,418 | 1,738 | $49K |
| J1817 | Insulin for administration through dme (i.e., insulin pump) per 50 units | 3.1% | 2,383 | 663 | $40K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 2.0% | 1,089 | 652 | $26K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.7% | 381 | 274 | $22K |
57 more codes
| 99402 | 1.6% | 815 | $21K | |
| 94060 | <1% | 424 | $12K | |
| 99358 | Prolong nursin fac eval 15m | <1% | 1,373 | $12K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 318 | $12K |
| G0247 | Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following if present: (1) local care of superficial wounds, (2) debridement of corns and calluses, and (3) trimming and debridement of nails | <1% | 1,365 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 231 | $7K |
| 93000 | <1% | 733 | $7K | |
| 99401 | <1% | 484 | $7K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 444 | $7K |
| 94618 | <1% | 351 | $7K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,223 | $7K |
| G0246 | Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear, and (3) patient education | <1% | 1,616 | $4K |
| 82962 | <1% | 2,211 | $4K | |
| 93923 | <1% | 97 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 442 | $3K |
| 36416 | <1% | 4,617 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 178 | $3K |
| G0245 | Initial physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) which must include: (1) the diagnosis of lops, (2) a patient history, (3) a physical examination that consists of at least the following elements: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of a protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear and (4) patient education | <1% | 932 | $3K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 41 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,558 | $3K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 1,056 | $2K |
| 99403 | <1% | 38 | $1K | |
| 92250 | <1% | 35 | $1K | |
| 99497 | <1% | 94 | $1K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 303 | $1K |
| 99205 | Prolong outpt/office vis | <1% | 20 | $1K |
| 99417 | Prolong home eval add 15m | <1% | 154 | $1K |
| 92546 | <1% | 42 | $975.46 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,113 | $797.06 |
| 92540 | <1% | 27 | $794.76 | |
| 80061 | Lipid panel | <1% | 172 | $674.47 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 14 | $566.23 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 23 | $560.16 |
| 99354 | <1% | 804 | $547.46 | |
| 95923 | <1% | 2,766 | $475.00 | |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | <1% | 120 | $414.29 |
| 99454 | <1% | 82 | $386.11 | |
| 96160 | <1% | 290 | $375.12 | |
| 95921 | <1% | 2,767 | $365.93 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,979 | $334.89 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 117 | $324.81 |
| 82947 | <1% | 171 | $234.64 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 43 | $229.80 |
| 90688 | <1% | 20 | $196.24 | |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | <1% | 99 | $187.81 |
| G2011 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes | <1% | 54 | $82.50 |
| 99457 | <1% | 13 | $75.00 | |
| 92547 | <1% | 42 | $73.20 | |
| 2022F | <1% | 35 | $0.07 | |
| 2026F | <1% | 35 | $0.07 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 0% | 466 | $0.00 |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 0% | 35 | $0.00 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 79 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 22 | $0.00 |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | 0% | 427 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 31 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMOORE, PATRICK (OWNER)
| Provider | Location | Paid |
|---|---|---|
| West Coast Surgical Specialists | Murrieta, CA | $1.73M |
| Louisiana Urgent Care of Opelousas, LLC | Opelousas, LA | $244K |
| Premier Urgent Care | Lafayette, LA | $42K |
| Patrick Daniel Moore Moore Foot Clinic | Kearney, NE | $675.76 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.